ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Monsanto gains a CRISPR platform

by Melody M. Bomgardner
August 28, 2017 | APPEARED IN VOLUME 95, ISSUE 34

Monsanto has signed a deal to use the CRISPR/Cas9 gene-editing platform of Seoul, South Korea-based ToolGen to develop products for agriculture. Gene-editing tools can add, delete, or change genes in plants much more quickly than traditional plant breeding and biotechnology methods can, Monsanto says. Monsanto is working to catch up with DuPont Pioneer, the first agricultural company to access CRISPR tools. Early this year Monsanto signed a nonexclusive deal for CRISPR/Cpf1 technology from the Broad Institute of MIT & Harvard.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment